SlideShare una empresa de Scribd logo
1 de 22
Descargar para leer sin conexión
MANAGEMENT OF PARKINSON’S
DISEASE
AAM. AMJATH
MEDICINE 4TH BATCH
FHCS-EUSL
Objectives
• To Understand the Goals in Management of
Parkinson’s Disease.
• Describe the Pharmacological Intervention in
Parkinson’s Disease.
• Describe the Non-Pharmacological
Intervention in Parkinson’s Disease.
• Describe the Surgical Treatments in
Parkinson’s Disease.
Management of parkinson’s disease
Management of parkinson’s disease
Goals of Management
• Maintain the function
• Avoid drug-induced complications
• In the Tx of PD,
Bradykinesia
Tremor
Rigidity
Abnormal posture
Respond Early in illness
• But…
Cognitive symptoms
Hypophonia
Autonomic dysfunction
Balance difficulties
Respond Poorly
Pharmacological Management of
Parkinson’s Disease.
Drugs used in PD
1. Levodopa and Carbidopa
2. Anticholinergics(Trihexyphenidyl, Benztropine)
3. Amantadine
4. Catechol-O-methyltransferase inhibitors (COMT
inhibitors
5. Monoamine oxidase type B (MAO-B)
(Give temporary relief from the symptoms of the disorder, but
not arrest or reverse the neuronal degeneration. )
Pharmacological Therapy in early PD
• ‘Early disease’ refers to PD in people who have
developed functional disability and require
symptomatic therapy.
• There is no single drug of choice in the initial
pharmacotherapy of early PD.
Options for initial pharmacotherapy in early PD
• The dose of levodopa should be kept as low as
possible to maintain good function in order to
reduce the development of motor complications.
• Beta blockers used in the symptomatic treatment
of selected people with postural tremor in PD.
• Anticholinergics may be used as a symptomatic
treatment typically in young people with early PD
and severe tremor
Pharmacological therapy in later PD
• ‘Later disease’ refers to PD in people on
levodopa who have developed motor
complications.
• There is no single drug of choice in the
pharmacotherapy of later PD.
• So, Adjuvant drugs are taken alongside with
Levodopa for it.
• Ex: COMT inhibitors, MAO-B inhibitors,
Dopamine agonist, Amantadine… etc.
Options for adjuvant pharmacotherapy in later PD
• Modified-release levodopa preparations may
be used to reduce motor complications in
people with later PD, but should not be drugs
of first choice.
• MAO-B & COMT inhibitors may be used to
reduce motor fluctuations and Amantadine
may be used to reduce dyskinesia in people
with later PD.
Management of parkinson’s disease
Non-Pharmacological Management of
Parkinson’s Disease.
• It includes,
 Rehabilitation.
Diet.
Physiotherapy
Speech & Language therapy
Occupational therapy
Rehabilitation
• Physiotherapy
It helps to improve the,
a. Mobility.
b. Flexibility.
c. Strength.
d. Gait speed.
e. Aerobic capacity.
f. Quality of life.
• Speech and language therapy
 Particular consideration should be given to :
a. improvement of vocal loudness and pitch range.
b. Ensuring an effective means of communication is
maintained throughout the course of the disease.
c. review and management to support safety and
efficiency of swallowing and to minimise the risk of
aspiration.
• Occupational therapy
 Particular consideration should be given to :
a. maintenance of work and family roles, home care
and leisure activities.
b. improvement and maintenance of transfers and
mobility.
c. improvement of personal self-care activities, such as
eating, drinking, washing and dressing.
Diet
• Diet should include high fibre foods and
plenty of water.
• When levodopa is introduced excessive
proteins are discouraged due to competition
between them to cross the BBB and intestine.
• So, To minimize interaction with proteins,
levodopa is recommended to be taken 30
minutes before meals.
Surgical Treatment
• In refractory cases, Surgical Tx is considered.
• Deep-brain stimulation (DBS) is presently the
most used Sx method.
• Here Subthalamic nucleus(STN) or Globus
pallidus interna (GPi) is stimulated.
• I˚ : Patients who suffer disability resulting from
levodopa-induced motor complications.
• CI : a) Cognitive Impairment.
b) Major Psy.illnesses
c) Substantial medical comorbidities
d) Advanced age
Management of parkinson’s disease
Management of parkinson’s disease

Más contenido relacionado

La actualidad más candente

Movement disorders
Movement disordersMovement disorders
Movement disordersHelao Silas
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s diseaseRenard Mulla
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxAmeena Kadar
 
Amyotrophic lateral sclerosis (als)
Amyotrophic lateral sclerosis (als)Amyotrophic lateral sclerosis (als)
Amyotrophic lateral sclerosis (als)meekhole
 
Parkinson's disease n management
Parkinson's disease n managementParkinson's disease n management
Parkinson's disease n managementDr. Rupendra Bharti
 
Parkinsonism - management
Parkinsonism - managementParkinsonism - management
Parkinsonism - managementKirsha K S
 
Guillain barre syndrome
Guillain barre syndromeGuillain barre syndrome
Guillain barre syndromePraveen Nagula
 
Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs Hajra Matloob (RPH)
 
Approach to dystonia
Approach to dystoniaApproach to dystonia
Approach to dystoniaNeurologyKota
 
Motor Neuron Disease
Motor Neuron DiseaseMotor Neuron Disease
Motor Neuron DiseaseNeurologyKota
 
Management of advanced parkinson’s disease
Management of advanced parkinson’s diseaseManagement of advanced parkinson’s disease
Management of advanced parkinson’s diseaseAhmed Koriesh
 
Alzheimer’s disease
Alzheimer’s diseaseAlzheimer’s disease
Alzheimer’s diseaseAkhil Joseph
 
Progressive supranuclear palsy richardson syndrome 060419
Progressive supranuclear palsy richardson syndrome 060419Progressive supranuclear palsy richardson syndrome 060419
Progressive supranuclear palsy richardson syndrome 060419Randy Rosenberg MD FAAN FACP
 
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...Chetan Ganteppanavar
 

La actualidad más candente (20)

Lecture section...Septic encephalopathy
Lecture section...Septic encephalopathyLecture section...Septic encephalopathy
Lecture section...Septic encephalopathy
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Movement disorders
Movement disordersMovement disorders
Movement disorders
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptx
 
Amyotrophic lateral sclerosis (als)
Amyotrophic lateral sclerosis (als)Amyotrophic lateral sclerosis (als)
Amyotrophic lateral sclerosis (als)
 
Parkinson's disease n management
Parkinson's disease n managementParkinson's disease n management
Parkinson's disease n management
 
Parkinsonism - management
Parkinsonism - managementParkinsonism - management
Parkinsonism - management
 
Guillain barre syndrome
Guillain barre syndromeGuillain barre syndrome
Guillain barre syndrome
 
Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs Parkisonism and anti parkinson's drugs
Parkisonism and anti parkinson's drugs
 
Approach to dystonia
Approach to dystoniaApproach to dystonia
Approach to dystonia
 
Motor Neuron Disease
Motor Neuron DiseaseMotor Neuron Disease
Motor Neuron Disease
 
Management of advanced parkinson’s disease
Management of advanced parkinson’s diseaseManagement of advanced parkinson’s disease
Management of advanced parkinson’s disease
 
Stroke rehabilitation
Stroke rehabilitationStroke rehabilitation
Stroke rehabilitation
 
Parkinsons ppt
Parkinsons pptParkinsons ppt
Parkinsons ppt
 
Alzheimer’s disease
Alzheimer’s diseaseAlzheimer’s disease
Alzheimer’s disease
 
Progressive supranuclear palsy richardson syndrome 060419
Progressive supranuclear palsy richardson syndrome 060419Progressive supranuclear palsy richardson syndrome 060419
Progressive supranuclear palsy richardson syndrome 060419
 
Parkinson s disease
Parkinson s diseaseParkinson s disease
Parkinson s disease
 
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...
Motor neuron disease - Etiology, Pathogenesis, Clinical Features, Classificat...
 
Movement disorders
Movement disordersMovement disorders
Movement disorders
 

Destacado

Dr Uma Nath - Parkinson's Disease in the Community
Dr Uma Nath - Parkinson's Disease in the CommunityDr Uma Nath - Parkinson's Disease in the Community
Dr Uma Nath - Parkinson's Disease in the CommunityCumbria Partnership
 
Recent advances in the management of parkinson disease
Recent advances in the management of parkinson diseaseRecent advances in the management of parkinson disease
Recent advances in the management of parkinson diseaseNeurologyKota
 
A Promotores Approach in the Management of Parkinson's Disease Interactive Se...
A Promotores Approach in the Management of Parkinson's Disease Interactive Se...A Promotores Approach in the Management of Parkinson's Disease Interactive Se...
A Promotores Approach in the Management of Parkinson's Disease Interactive Se...Mano y Corazon Health Care Conference
 
Advances in Management of Parkinson's Disease
Advances in Management of Parkinson's DiseaseAdvances in Management of Parkinson's Disease
Advances in Management of Parkinson's DiseaseSultana Shaikh
 
Neuropsychiatric Symptoms of Parkinson Disease
Neuropsychiatric Symptoms of Parkinson Disease Neuropsychiatric Symptoms of Parkinson Disease
Neuropsychiatric Symptoms of Parkinson Disease Ade Wijaya
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Diseaseguest27ee33
 
Approach to headache
Approach to headacheApproach to headache
Approach to headacheOmkar Singh
 

Destacado (8)

Dr Uma Nath - Parkinson's Disease in the Community
Dr Uma Nath - Parkinson's Disease in the CommunityDr Uma Nath - Parkinson's Disease in the Community
Dr Uma Nath - Parkinson's Disease in the Community
 
Recent advances in the management of parkinson disease
Recent advances in the management of parkinson diseaseRecent advances in the management of parkinson disease
Recent advances in the management of parkinson disease
 
A Promotores Approach in the Management of Parkinson's Disease Interactive Se...
A Promotores Approach in the Management of Parkinson's Disease Interactive Se...A Promotores Approach in the Management of Parkinson's Disease Interactive Se...
A Promotores Approach in the Management of Parkinson's Disease Interactive Se...
 
Advances in Management of Parkinson's Disease
Advances in Management of Parkinson's DiseaseAdvances in Management of Parkinson's Disease
Advances in Management of Parkinson's Disease
 
Neuropsychiatric Symptoms of Parkinson Disease
Neuropsychiatric Symptoms of Parkinson Disease Neuropsychiatric Symptoms of Parkinson Disease
Neuropsychiatric Symptoms of Parkinson Disease
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
Approach to headache
Approach to headacheApproach to headache
Approach to headache
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 

Similar a Management of parkinson’s disease

Parkinsonism Treatment
Parkinsonism TreatmentParkinsonism Treatment
Parkinsonism TreatmentAsiya Naaz
 
parkinsonnnnn disease (3).pptx
parkinsonnnnn disease (3).pptxparkinsonnnnn disease (3).pptx
parkinsonnnnn disease (3).pptxAratiPaudel
 
Introduction to psychopharmacology
Introduction to psychopharmacologyIntroduction to psychopharmacology
Introduction to psychopharmacology1davids1
 
Introduction to psychopharmacology
Introduction to psychopharmacologyIntroduction to psychopharmacology
Introduction to psychopharmacologyMD Specialclass
 
Introduction to psychopharmacology
Introduction to psychopharmacologyIntroduction to psychopharmacology
Introduction to psychopharmacologyguest173187
 
Introduction to psychopharmacology
Introduction to psychopharmacologyIntroduction to psychopharmacology
Introduction to psychopharmacologyguest173187
 
Pharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons diseasePharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons diseaseQudsia Nuzhat
 
THERAPEUTIC MODALITIES IN PSYCHIATRY.pptx
THERAPEUTIC MODALITIES IN PSYCHIATRY.pptxTHERAPEUTIC MODALITIES IN PSYCHIATRY.pptx
THERAPEUTIC MODALITIES IN PSYCHIATRY.pptxsujitha108318
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's diseaseMerin Babu
 
Anti psychotic drugs
Anti psychotic drugsAnti psychotic drugs
Anti psychotic drugsDr Renju Ravi
 
Parkinsons disease o.j
Parkinsons disease o.jParkinsons disease o.j
Parkinsons disease o.jOkumu Jeremiah
 
Hanipsych, aripiprazole as antidepressant
Hanipsych, aripiprazole as antidepressantHanipsych, aripiprazole as antidepressant
Hanipsych, aripiprazole as antidepressantHani Hamed
 
Parkinson's Disease (PD)
Parkinson's Disease (PD)Parkinson's Disease (PD)
Parkinson's Disease (PD)Arwa M. Amin
 
RECENT ADVANCES IN THE TREATMENT OF PARKINSON’S DISEASE.pptx
RECENT ADVANCES IN THE TREATMENT OF PARKINSON’S DISEASE.pptxRECENT ADVANCES IN THE TREATMENT OF PARKINSON’S DISEASE.pptx
RECENT ADVANCES IN THE TREATMENT OF PARKINSON’S DISEASE.pptxashharnomani
 

Similar a Management of parkinson’s disease (20)

Parkinsonism Treatment
Parkinsonism TreatmentParkinsonism Treatment
Parkinsonism Treatment
 
approach to parkinsonism by Dr Ganesh.pptx
approach to parkinsonism by Dr Ganesh.pptxapproach to parkinsonism by Dr Ganesh.pptx
approach to parkinsonism by Dr Ganesh.pptx
 
parkinsonnnnn disease (3).pptx
parkinsonnnnn disease (3).pptxparkinsonnnnn disease (3).pptx
parkinsonnnnn disease (3).pptx
 
PSYCHOPHARMACOLOGY
PSYCHOPHARMACOLOGYPSYCHOPHARMACOLOGY
PSYCHOPHARMACOLOGY
 
Introduction to psychopharmacology
Introduction to psychopharmacologyIntroduction to psychopharmacology
Introduction to psychopharmacology
 
Introduction to psychopharmacology
Introduction to psychopharmacologyIntroduction to psychopharmacology
Introduction to psychopharmacology
 
Introduction to psychopharmacology
Introduction to psychopharmacologyIntroduction to psychopharmacology
Introduction to psychopharmacology
 
Introduction to psychopharmacology
Introduction to psychopharmacologyIntroduction to psychopharmacology
Introduction to psychopharmacology
 
Parkinson's diseases
Parkinson's diseasesParkinson's diseases
Parkinson's diseases
 
Pharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons diseasePharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons disease
 
Opioids
OpioidsOpioids
Opioids
 
THERAPEUTIC MODALITIES IN PSYCHIATRY.pptx
THERAPEUTIC MODALITIES IN PSYCHIATRY.pptxTHERAPEUTIC MODALITIES IN PSYCHIATRY.pptx
THERAPEUTIC MODALITIES IN PSYCHIATRY.pptx
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
Anti psychotic drugs
Anti psychotic drugsAnti psychotic drugs
Anti psychotic drugs
 
PARKINSON.pptx
PARKINSON.pptxPARKINSON.pptx
PARKINSON.pptx
 
Selection of mood stabilizers
Selection of mood stabilizers Selection of mood stabilizers
Selection of mood stabilizers
 
Parkinsons disease o.j
Parkinsons disease o.jParkinsons disease o.j
Parkinsons disease o.j
 
Hanipsych, aripiprazole as antidepressant
Hanipsych, aripiprazole as antidepressantHanipsych, aripiprazole as antidepressant
Hanipsych, aripiprazole as antidepressant
 
Parkinson's Disease (PD)
Parkinson's Disease (PD)Parkinson's Disease (PD)
Parkinson's Disease (PD)
 
RECENT ADVANCES IN THE TREATMENT OF PARKINSON’S DISEASE.pptx
RECENT ADVANCES IN THE TREATMENT OF PARKINSON’S DISEASE.pptxRECENT ADVANCES IN THE TREATMENT OF PARKINSON’S DISEASE.pptx
RECENT ADVANCES IN THE TREATMENT OF PARKINSON’S DISEASE.pptx
 

Último

How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17Celine George
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and stepobaje godwin sunday
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfTechSoup
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICESayali Powar
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...Nguyen Thanh Tu Collection
 
CAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxCAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxSaurabhParmar42
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17Celine George
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.EnglishCEIPdeSigeiro
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxEduSkills OECD
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17Celine George
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptxSandy Millin
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxheathfieldcps1
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?TechSoup
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphNetziValdelomar1
 

Último (20)

How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and step
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICE
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
 
CAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptxCAULIFLOWER BREEDING 1 Parmar pptx
CAULIFLOWER BREEDING 1 Parmar pptx
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
Prelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quizPrelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quiz
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptx
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a Paragraph
 

Management of parkinson’s disease

  • 1. MANAGEMENT OF PARKINSON’S DISEASE AAM. AMJATH MEDICINE 4TH BATCH FHCS-EUSL
  • 2. Objectives • To Understand the Goals in Management of Parkinson’s Disease. • Describe the Pharmacological Intervention in Parkinson’s Disease. • Describe the Non-Pharmacological Intervention in Parkinson’s Disease. • Describe the Surgical Treatments in Parkinson’s Disease.
  • 5. Goals of Management • Maintain the function • Avoid drug-induced complications • In the Tx of PD, Bradykinesia Tremor Rigidity Abnormal posture Respond Early in illness
  • 6. • But… Cognitive symptoms Hypophonia Autonomic dysfunction Balance difficulties Respond Poorly
  • 7. Pharmacological Management of Parkinson’s Disease. Drugs used in PD 1. Levodopa and Carbidopa 2. Anticholinergics(Trihexyphenidyl, Benztropine) 3. Amantadine 4. Catechol-O-methyltransferase inhibitors (COMT inhibitors 5. Monoamine oxidase type B (MAO-B) (Give temporary relief from the symptoms of the disorder, but not arrest or reverse the neuronal degeneration. )
  • 8. Pharmacological Therapy in early PD • ‘Early disease’ refers to PD in people who have developed functional disability and require symptomatic therapy. • There is no single drug of choice in the initial pharmacotherapy of early PD.
  • 9. Options for initial pharmacotherapy in early PD
  • 10. • The dose of levodopa should be kept as low as possible to maintain good function in order to reduce the development of motor complications. • Beta blockers used in the symptomatic treatment of selected people with postural tremor in PD. • Anticholinergics may be used as a symptomatic treatment typically in young people with early PD and severe tremor
  • 11. Pharmacological therapy in later PD • ‘Later disease’ refers to PD in people on levodopa who have developed motor complications. • There is no single drug of choice in the pharmacotherapy of later PD. • So, Adjuvant drugs are taken alongside with Levodopa for it. • Ex: COMT inhibitors, MAO-B inhibitors, Dopamine agonist, Amantadine… etc.
  • 12. Options for adjuvant pharmacotherapy in later PD
  • 13. • Modified-release levodopa preparations may be used to reduce motor complications in people with later PD, but should not be drugs of first choice. • MAO-B & COMT inhibitors may be used to reduce motor fluctuations and Amantadine may be used to reduce dyskinesia in people with later PD.
  • 15. Non-Pharmacological Management of Parkinson’s Disease. • It includes,  Rehabilitation. Diet. Physiotherapy Speech & Language therapy Occupational therapy
  • 16. Rehabilitation • Physiotherapy It helps to improve the, a. Mobility. b. Flexibility. c. Strength. d. Gait speed. e. Aerobic capacity. f. Quality of life.
  • 17. • Speech and language therapy  Particular consideration should be given to : a. improvement of vocal loudness and pitch range. b. Ensuring an effective means of communication is maintained throughout the course of the disease. c. review and management to support safety and efficiency of swallowing and to minimise the risk of aspiration.
  • 18. • Occupational therapy  Particular consideration should be given to : a. maintenance of work and family roles, home care and leisure activities. b. improvement and maintenance of transfers and mobility. c. improvement of personal self-care activities, such as eating, drinking, washing and dressing.
  • 19. Diet • Diet should include high fibre foods and plenty of water. • When levodopa is introduced excessive proteins are discouraged due to competition between them to cross the BBB and intestine. • So, To minimize interaction with proteins, levodopa is recommended to be taken 30 minutes before meals.
  • 20. Surgical Treatment • In refractory cases, Surgical Tx is considered. • Deep-brain stimulation (DBS) is presently the most used Sx method. • Here Subthalamic nucleus(STN) or Globus pallidus interna (GPi) is stimulated. • I˚ : Patients who suffer disability resulting from levodopa-induced motor complications. • CI : a) Cognitive Impairment. b) Major Psy.illnesses c) Substantial medical comorbidities d) Advanced age